This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- 18F-FDG PET/CT in the Management of Osteosarcoma
- 18F-FDG PET/CT in the Management of Osteosarcoma
- Combination of 18F-FDG PET/CT and Diffusion-Weighted MR Imaging as a Predictor of Histologic Response to Neoadjuvant Chemotherapy: Preliminary Results in Osteosarcoma
- Imaging features of primary and secondary malignant tumours of the sacrum
- Imaging in Sarcoma
- Added Value of Baseline 18F-FDG Uptake in Serial 18F-FDG PET for Evaluation of Response of Solid Extracerebral Tumors to Systemic Cytotoxic Neoadjuvant Treatment: A Meta-Analysis
- Prediction Model of Chemotherapy Response in Osteosarcoma by 18F-FDG PET and MRI
- Measuring Response with FDG-PET: Methodological Aspects
- 18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
- Controversies in the Management of Oropharynx Cancer
- Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine
- PET for Sarcomas Other Than Gastrointestinal Stromal Tumors
- Ewing's Sarcoma Family of Tumors: Current Management.
- PET for response assessment in oncology: radiotherapy and chemotherapy
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
- Biology and Therapeutic Advances for Pediatric Osteosarcoma
- Positron Emission Tomography in Non-Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use
- PET Imaging of Osteosarcoma
- Prognostic Significance of 18F-FDG and 99mTc-Methylene Diphosphonate Uptake in Primary Osteosarcoma
- Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas
- Is There a Role for FDG PET in the Diagnosis of Musculoskeletal Neoplasms?
- Grading of Tumors and Tumorlike Lesions of Bone: Evaluation by FDG PET